Next Article in Journal
Cost-Effectiveness of Sacituzumab Govitecan Versus Chemotherapy in Metastatic Triple—Negative Breast Cancer in Taiwan
Previous Article in Journal
CHEcking Diagnostic Differential Ability of Real Baseline Variables and Frailty Scores in Tolerance of Anti-Cancer Systemic Therapy in OldEr Patients (CHEDDAR-TOASTIE)
 
 
Correction

Article Versions Notes

Cancers 2025, 17(20), 3304; https://doi.org/10.3390/cancers17203304
Action Date Notes Link
article xml uploaded. 13 October 2025 11:43 CEST Original file -
article xml file uploaded 13 October 2025 11:43 CEST Update -
article pdf uploaded. 13 October 2025 11:43 CEST Version of Record https://www.mdpi.com/2072-6694/17/20/3304/pdf-vor
article html file updated 13 October 2025 11:44 CEST Original file -
article xml file uploaded 14 October 2025 04:51 CEST Update -
article xml uploaded. 14 October 2025 04:51 CEST Update -
article pdf uploaded. 14 October 2025 04:51 CEST Updated version of record https://www.mdpi.com/2072-6694/17/20/3304/pdf-vor
article html file updated 14 October 2025 04:52 CEST Update -
article xml uploaded. 22 October 2025 03:54 CEST Update -
article xml file uploaded 22 October 2025 03:54 CEST Update -
article pdf uploaded. 22 October 2025 03:55 CEST Updated version of record https://www.mdpi.com/2072-6694/17/20/3304/pdf-vor
article html file updated 22 October 2025 03:56 CEST Update -
article xml file uploaded 22 October 2025 04:22 CEST Update -
article xml uploaded. 22 October 2025 04:22 CEST Update https://www.mdpi.com/2072-6694/17/20/3304/xml
article pdf uploaded. 22 October 2025 04:22 CEST Updated version of record https://www.mdpi.com/2072-6694/17/20/3304/pdf
article html file updated 22 October 2025 04:24 CEST Update -
article html file updated 22 October 2025 11:04 CEST Update -
article html file updated 22 October 2025 12:11 CEST Update https://www.mdpi.com/2072-6694/17/20/3304/html
Back to TopTop